Generation of cell types with myoepithelial and mesenchymal phenotypes during the conversion of rat mammary tumor epithelial stem cells into elongated cells.
Epithelial cell lines isolated from benign rat mammary tumors converted to elongated cells that showed some aspects of myoepithelial differentiation. This cellular conversion was blocked in cells isolated from malignant tumors. For investigation of the pathway of the conversion, a rat mammary epithelial cell line (Rama 25) that converted to elongated cells through a series of morphologically distinct intermediates was isolated. These intermediates formed a series in the order: Rama 25, Rama 25-I2, Rama 25-I1, Rama 25-I4, and elongated cells. These cell lines were examined for aspects of myoepithelial or mesenchymal differentiation with the use of a polyclonal antibody to type IV collagen and a keratin monoclonal antibody, LP34 (myoepithelial markers), or a polyclonal antibody to type I procollagen (mesenchymal marker) for cells grown on plastic or as tumors in nude mice. The more epithelial-like cell lines Rama 25 and Rama 25-I2 produced relatively small amounts of type IV collagen and did not stain with LP34 or anti-type I procollagen. The flatter, polygonal cell line Rama 25-I1 stained more strongly with the antibody to type IV collagen but did not stain with anti-type I procollagen. Rama 25-I1 cells, and to a lesser extent Rama 25-I4 cells in tumors, contained a network of cytoplasmic filaments that stained strongly with LP34. The elongated cells, Rama 25-I4 and Rama 25-floaters (Rama 25-FL), did not stain with LP34 in vitro but produced an extracellular matrix that stained with antibodies to both type I procollagen and type IV collagen. The results obtained with these marker proteins suggested that, in this series of morphologic intermediates, the myoepithelial phenotype was best expressed in Rama 25-I1 cells and to a lesser extent in 25-I4 cells. However, this phenotype was relatively unstable, converting to elongated cells, some of which have decreased myoepithelial and increased mesenchymal characteristics. Such a pathway may explain the mixed population of cells seen in some types of benign mammary tumor.
D000818:Animals; D000911:Antibodies, Monoclonal; D002454:Cell Differentiation; D002460:Cell Line; D003094:Collagen / Q000032:analysis; D004848:Epithelium / Q000473:pathology; D005260:Female; D006651:Histocytochemistry; D007158:Immunologic Techniques; D007633:Keratins / Q000032:analysis; D008325:Mammary Neoplasms, Experimental / Q000473:pathology*; D051379:Mice; D008819:Mice, Nude; D014411:Neoplastic Stem Cells / Q000473:pathology*; D011347:Procollagen / Q000032:analysis; D051381:Rats
D000911:Antibodies, Monoclonal; D011347:Procollagen; D007633:Keratins; D003094:Collagen